Ruiz M, Braunstein Z, McLaughlin E, Mishra A, Porcu P, Brammer JE. Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. haematol [Internet]. 2025Apr.1 [cited 2025Jun.24];110(4):995-8. Available from: https://haematologica.org/article/view/11823